Loading...
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome
Inflammatory breast cancer (IBC) represents a rare but aggressive and lethal form of locally advanced breast cancer (LABC) and frequently with HER-2 neu overexpressed or amplified. We retrospectively identified 16 newly diagnosed HER-2/neu-positive IBC patients who were treated with preoperative tra...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3097300/ https://ncbi.nlm.nih.gov/pubmed/20626396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-4741.2010.00953.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|